A20 (TNFAIP3) deficiency in myeloid cells triggers erosive polyarthritis resembling rheumatoid arthritis

M Matmati, P Jacques, J Maelfait, E Verheugen… - Nature …, 2011 - nature.com
M Matmati, P Jacques, J Maelfait, E Verheugen, M Kool, M Sze, L Geboes, E Louagie…
Nature genetics, 2011nature.com
Abstract A20 (TNFAIP3) is a protein that is involved in the negative feedback regulation of
NF-κB signaling in response to specific proinflammatory stimuli in different cell types and
has been suggested as a susceptibility gene for rheumatoid arthritis. To define the
contribution of A20 to rheumatoid arthritis pathology, we generated myeloid-specific A20-
deficient mice and show that specific ablation of Tnfaip3 in myeloid cells results in
spontaneous development of a severe destructive polyarthritis with many features of …
Abstract
A20 (TNFAIP3) is a protein that is involved in the negative feedback regulation of NF-κB signaling in response to specific proinflammatory stimuli in different cell types and has been suggested as a susceptibility gene for rheumatoid arthritis. To define the contribution of A20 to rheumatoid arthritis pathology, we generated myeloid-specific A20-deficient mice and show that specific ablation of Tnfaip3 in myeloid cells results in spontaneous development of a severe destructive polyarthritis with many features of rheumatoid arthritis. Myeloid-A20–deficient mice have high levels of inflammatory cytokines in their serum, consistent with a sustained NF-κB activation and higher TNF production by macrophages. Destructive polyarthritis in myeloid A20 knockout mice was TLR4-MyD88 and IL-6 dependent but was TNF independent. Myeloid A20 deficiency also promoted osteoclastogenesis in mice. Together, these observations indicate a critical and cell-specific function for A20 in the etiology of rheumatoid arthritis, supporting the idea of developing A20 modulatory drugs as cell-targeted therapies.
nature.com